GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (LTS:0A5J) » Definitions » Margin of Safety % (DCF Earnings Based)

Dermapharm Holding SE (LTS:0A5J) Margin of Safety % (DCF Earnings Based) : 0.60% (As of Apr. 26, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Dermapharm Holding SE Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2025-04-26), Dermapharm Holding SE's Predictability Rank is 5-Stars. Dermapharm Holding SE's intrinsic value calculated from the Discounted Earnings model is €38.33 and current share price is €38.10. Consequently,

Dermapharm Holding SE's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is 0.60%.

Competitive Comparison of Dermapharm Holding SE's Margin of Safety % (DCF Earnings Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dermapharm Holding SE's Margin of Safety % (DCF Earnings Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's Margin of Safety % (DCF Earnings Based) falls into.


;
;

Dermapharm Holding SE Margin of Safety % (DCF Earnings Based) Calculation

Dermapharm Holding SE's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(38.33-38.10)/38.33
=0.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

Dermapharm Holding SE Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermapharm Holding SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (LTS:0A5J) » Definitions » Margin of Safety % (DCF Earnings Based)
Comparable Companies
XTER:EVT XTER:B8FK ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI SZSE:000538 UTHR BOM:500087 TSE:4507 SHSE:688506 NSE:TORNTPHARM BOM:543904
Traded in Other Exchanges
DMPHF:USA DMPd:UK DMP:Germany
Address
Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Website
https://www.dermapharm.com
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.

Dermapharm Holding SE Headlines

No Headlines